Header Logo

Connection

SHREYASKUMAR PATEL to Sarcoma

Back to Details
This is a "connection" page, showing publications SHREYASKUMAR PATEL has written about Sarcoma.
SHREYASKUMAR PATEL
Connection Strength
6.075
Sarcoma
  1. Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. Lancet Oncol. 2017 11; 18(11):1493-1501.
    View in: PubMed
    Score: 0.274
  2. Trabectedin and Eribulin: Where Do They Fit in the Management of Soft Tissue Sarcoma? Curr Treat Options Oncol. 2017 06; 18(6):34.
    View in: PubMed
    Score: 0.268
  3. Chemotherapy for soft tissue sarcoma. Cancer. 2016 10; 122(19):2952-60.
    View in: PubMed
    Score: 0.252
  4. Chemotherapy for bone sarcomas in adults: the MD anderson experience. Am Soc Clin Oncol Educ Book. 2015; e656-60.
    View in: PubMed
    Score: 0.226
  5. Fifty years of advances in sarcoma treatment: moving the needle from conventional chemotherapy to targeted therapy. Am Soc Clin Oncol Educ Book. 2014; 259-62.
    View in: PubMed
    Score: 0.211
  6. Adjuvant chemotherapy for soft tissue sarcomas. Surg Oncol Clin N Am. 2012 Apr; 21(2):243-53.
    View in: PubMed
    Score: 0.185
  7. Should patients with high-risk soft tissue sarcoma receive adjuvant chemotherapy? Oncologist. 2009 Oct; 14(10):1003-12.
    View in: PubMed
    Score: 0.157
  8. Phase II study of intravenous TZT-1027 in patients with advanced or metastatic soft-tissue sarcomas with prior exposure to anthracycline-based chemotherapy. Cancer. 2006 Dec 15; 107(12):2881-7.
    View in: PubMed
    Score: 0.130
  9. New drug developments for patients with metastatic soft tissue sarcoma. Curr Oncol Rep. 2005 Jul; 7(4):300-6.
    View in: PubMed
    Score: 0.117
  10. Recent studies in novel therapy for metastatic sarcomas. Hematol Oncol Clin North Am. 2005 Jun; 19(3):573-90, viii.
    View in: PubMed
    Score: 0.116
  11. Recent developments in salvage chemotherapy for patients with metastatic soft tissue sarcoma. Drugs. 2005; 65(2):167-78.
    View in: PubMed
    Score: 0.113
  12. A two-arm phase II study of temozolomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomas. Cancer. 2003 Dec 15; 98(12):2693-9.
    View in: PubMed
    Score: 0.105
  13. Advances in neoadjuvant chemotherapy in soft tissue sarcomas. Curr Treat Options Oncol. 2003 Dec; 4(6):433-9.
    View in: PubMed
    Score: 0.105
  14. Phase I trial of preoperative concurrent doxorubicin and radiation therapy, surgical resection, and intraoperative electron-beam radiation therapy for patients with localized retroperitoneal sarcoma. J Clin Oncol. 2003 Aug 15; 21(16):3092-7.
    View in: PubMed
    Score: 0.103
  15. Results of a 2-arm Phase II study of 9-nitrocamptothecin in patients with advanced soft-tissue sarcomas. Cancer. 2003 Jun 01; 97(11):2848-52.
    View in: PubMed
    Score: 0.101
  16. The follow-up of adult soft-tissue sarcomas. Semin Oncol. 2003 Jun; 30(3):413-6.
    View in: PubMed
    Score: 0.101
  17. Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101). Clin Cancer Res. 2023 05 01; 29(9):1708-1718.
    View in: PubMed
    Score: 0.101
  18. Developing therapeutic pharmaceuticals for the treatment of soft-tissue sarcomas. Expert Opin Investig Drugs. 2002 Dec; 11(12):1789-93.
    View in: PubMed
    Score: 0.098
  19. Systemic therapy for advanced soft-tissue sarcomas. Curr Oncol Rep. 2002 Jul; 4(4):299-304.
    View in: PubMed
    Score: 0.095
  20. Preoperative chemoradiation treatment strategies for localized sarcoma. Ann Surg Oncol. 2002 Jul; 9(6):535-42.
    View in: PubMed
    Score: 0.095
  21. Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma. Nat Commun. 2022 06 16; 13(1):3477.
    View in: PubMed
    Score: 0.095
  22. Identified Enrollment Challenges of Adolescent and Young Adult Patients on the Nonchemotherapy Arm of Children's Oncology Group Study ARST1321. J Adolesc Young Adult Oncol. 2022 06; 11(3):328-332.
    View in: PubMed
    Score: 0.090
  23. Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer. Cancer Med. 2021 06; 10(11):3565-3574.
    View in: PubMed
    Score: 0.088
  24. Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities. Cancer. 2021 08 15; 127(16):2934-2942.
    View in: PubMed
    Score: 0.088
  25. Evaluating the Soft Tissue Sarcoma Paradigm for the Local Management of Extraskeletal Ewing Sarcoma. Oncologist. 2021 03; 26(3):250-260.
    View in: PubMed
    Score: 0.085
  26. Real-world outcomes of patients with locally advanced or metastatic epithelioid sarcoma. Cancer. 2021 04 15; 127(8):1311-1317.
    View in: PubMed
    Score: 0.085
  27. Sarcoma European and Latin American Network (SELNET) Recommendations on Prioritization in Sarcoma Care During the COVID-19 Pandemic. Oncologist. 2020 10; 25(10):e1562-e1573.
    View in: PubMed
    Score: 0.084
  28. Management of peritoneal and hepatic metastases from gastrointestinal stromal tumors. Surg Oncol. 2000 Aug; 9(2):67-70.
    View in: PubMed
    Score: 0.083
  29. Radiation-induced sarcoma. Curr Treat Options Oncol. 2000 Aug; 1(3):258-61.
    View in: PubMed
    Score: 0.083
  30. New agents in the treatment of soft-tissue sarcomas. Expert Opin Investig Drugs. 2000 Jul; 9(7):1545-51.
    View in: PubMed
    Score: 0.083
  31. Extraskeletal Myxoid Chondrosarcomas: Combined Modality Therapy With Both Radiation and Surgery Improves Local Control. Am J Clin Oncol. 2019 10; 42(10):744-748.
    View in: PubMed
    Score: 0.079
  32. New chemotherapeutic strategies for soft tissue sarcomas. Semin Surg Oncol. 1999 Jul-Aug; 17(1):47-51.
    View in: PubMed
    Score: 0.077
  33. A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb-004) in metastatic soft-tissue sarcomas. Cancer. 2019 07 15; 125(14):2445-2454.
    View in: PubMed
    Score: 0.076
  34. Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma. BMC Cancer. 2018 Sep 24; 18(1):913.
    View in: PubMed
    Score: 0.073
  35. Results of two consecutive trials of dose-intensive chemotherapy with doxorubicin and ifosfamide in patients with sarcomas. Am J Clin Oncol. 1998 Jun; 21(3):317-21.
    View in: PubMed
    Score: 0.072
  36. The challenge of the management of adolescents and young adults with soft tissue sarcomas. Pediatr Blood Cancer. 2018 07; 65(7):e27013.
    View in: PubMed
    Score: 0.070
  37. Phase II study of CI-980 (NSC 635370) in patients with previously treated advanced soft-tissue sarcomas. Invest New Drugs. 1998; 16(1):87-92.
    View in: PubMed
    Score: 0.070
  38. Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials. J Immunother Cancer. 2017 12 19; 5(1):100.
    View in: PubMed
    Score: 0.070
  39. Outcomes of patients with sarcoma enrolled in clinical trials of pazopanib combined with histone deacetylase, mTOR, Her2, or MEK inhibitors. Sci Rep. 2017 11 21; 7(1):15963.
    View in: PubMed
    Score: 0.069
  40. The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope. Curr Oncol Rep. 2017 Oct 13; 19(12):78.
    View in: PubMed
    Score: 0.069
  41. High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence. J Clin Oncol. 1997 Jun; 15(6):2378-84.
    View in: PubMed
    Score: 0.067
  42. Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved Therapies. Sci Rep. 2016 10 17; 6:35448.
    View in: PubMed
    Score: 0.064
  43. Ifosfamide in sarcomas: is it a schedule-dependent drug? Cancer Invest. 1996; 14(3):290-1.
    View in: PubMed
    Score: 0.061
  44. SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcoma. Cancer. 2016 Mar 15; 122(6):868-74.
    View in: PubMed
    Score: 0.061
  45. Phase 1 adaptive dose-finding study of neoadjuvant gemcitabine combined with radiation therapy for patients with high-risk extremity and trunk soft tissue sarcoma. Cancer. 2015 Oct 15; 121(20):3659-67.
    View in: PubMed
    Score: 0.059
  46. Chemotherapy for soft-tissue sarcomas. Oncology (Williston Park). 2015 Jan; 29(1):43-50.
    View in: PubMed
    Score: 0.057
  47. Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)?. Ann Oncol. 2015 May; 26(5):865-872.
    View in: PubMed
    Score: 0.055
  48. Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas. Eur J Cancer. 2014 Apr; 50(6):1137-47.
    View in: PubMed
    Score: 0.053
  49. Clinical outcomes and safety with trabectedin therapy in patients with advanced soft tissue sarcomas following failure of prior chemotherapy: results of a worldwide expanded access program study. Ann Oncol. 2013 Jun; 24(6):1703-9.
    View in: PubMed
    Score: 0.050
  50. Prognostic significance of elevated D-dimer for survival in patients with sarcoma. Am J Clin Oncol. 2012 Oct; 35(5):462-7.
    View in: PubMed
    Score: 0.048
  51. Standard and high dose chemotherapy for advanced soft tissue sarcomas. Ann Oncol. 1992 Apr; 3 Suppl 2:S81-3.
    View in: PubMed
    Score: 0.047
  52. Soft tissue sarcomas of the popliteal fossa: a single-institution retrospective review. Cancer. 2011 Jun 15; 117(12):2728-34.
    View in: PubMed
    Score: 0.043
  53. Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial. Ann Intern Med. 2010 Sep 21; 153(6):358-67.
    View in: PubMed
    Score: 0.042
  54. Sarcomas with spindle cell morphology. Semin Oncol. 2009 Aug; 36(4):324-37.
    View in: PubMed
    Score: 0.039
  55. Phase II multicenter trial of imatinib in 10 histologic subtypes of sarcoma using a bayesian hierarchical statistical model. J Clin Oncol. 2009 Jul 01; 27(19):3148-53.
    View in: PubMed
    Score: 0.038
  56. Surgical management of primary and metastatic sarcoma of the mobile spine. J Neurosurg Spine. 2008 Aug; 9(2):120-8.
    View in: PubMed
    Score: 0.036
  57. Potential combination chemotherapy approaches for advanced adult-type soft-tissue sarcoma. Am J Clin Dermatol. 2008; 9(4):207-17.
    View in: PubMed
    Score: 0.035
  58. Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected]. J Clin Oncol. 2007 Jul 01; 25(19):2755-63.
    View in: PubMed
    Score: 0.034
  59. Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment. Int J Radiat Oncol Biol Phys. 2007 Jan 01; 67(1):158-63.
    View in: PubMed
    Score: 0.032
  60. Once daily, oral, outpatient quinolone monotherapy for low-risk cancer patients with fever and neutropenia: a pilot study of 40 patients based on validated risk-prediction rules. Cancer. 2006 Jun 01; 106(11):2489-94.
    View in: PubMed
    Score: 0.031
  61. Phase I trial of preoperative doxorubicin-based concurrent chemoradiation and surgical resection for localized extremity and body wall soft tissue sarcomas. J Clin Oncol. 2004 Aug 15; 22(16):3375-80.
    View in: PubMed
    Score: 0.028
  62. Interval between surgery and radiotherapy: effect on local control of soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 2004 Apr 01; 58(5):1461-7.
    View in: PubMed
    Score: 0.027
  63. A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma. Nat Cancer. 2024 Apr; 5(4):625-641.
    View in: PubMed
    Score: 0.027
  64. Prognostic factors for disease-specific survival after first relapse of soft-tissue sarcoma: analysis of 402 patients with disease relapse after initial conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2003 Nov 01; 57(3):739-47.
    View in: PubMed
    Score: 0.026
  65. Preoperative vs. postoperative radiation therapy for soft tissue sarcoma: a retrospective comparative evaluation of disease outcome. Int J Radiat Oncol Biol Phys. 2003 Jun 01; 56(2):482-8.
    View in: PubMed
    Score: 0.025
  66. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer. 2003 May 15; 97(10):2530-43.
    View in: PubMed
    Score: 0.025
  67. Surgical margins and reresection in the management of patients with soft tissue sarcoma using conservative surgery and radiation therapy. Cancer. 2003 May 15; 97(10):2544-53.
    View in: PubMed
    Score: 0.025
  68. Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas. Cancer. 2002 Sep 01; 95(5):1120-6.
    View in: PubMed
    Score: 0.024
  69. Tumor volume as a prognostic factor for sarcomatosis. Cancer. 2002 May 01; 94(9):2441-6.
    View in: PubMed
    Score: 0.024
  70. Cost-effectiveness of staging computed tomography of the chest in patients with T2 soft tissue sarcomas. Cancer. 2002 Jan 01; 94(1):197-204.
    View in: PubMed
    Score: 0.023
  71. Spermatic cord sarcoma: outcome, patterns of failure and management. J Urol. 2001 Oct; 166(4):1306-10.
    View in: PubMed
    Score: 0.023
  72. Epithelioid sarcoma: results of conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2001 Oct 01; 51(2):384-91.
    View in: PubMed
    Score: 0.023
  73. Concurrent ifosfamide-based chemotherapy and irradiation. Analysis of treatment-related toxicity in 43 patients with sarcoma. Cancer. 2001 Sep 15; 92(6):1550-5.
    View in: PubMed
    Score: 0.023
  74. Utility of chest computed tomography for staging in patients with T1 extremity soft tissue sarcomas. Cancer. 2001 Aug 15; 92(4):863-8.
    View in: PubMed
    Score: 0.022
  75. Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation. J Clin Oncol. 2001 Aug 01; 19(15):3483-9.
    View in: PubMed
    Score: 0.022
  76. Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution. Cancer. 2001 Feb 01; 91(3):585-91.
    View in: PubMed
    Score: 0.022
  77. Radiation Therapy Oncology Group. Research Plan 2002-2006. Sarcoma Committee. Int J Radiat Oncol Biol Phys. 2001; 51(3 Suppl 2):53-5.
    View in: PubMed
    Score: 0.021
  78. Impact of neoadjuvant chemotherapy on postoperative morbidity in soft tissue sarcomas. J Clin Oncol. 2000 Oct 01; 18(19):3378-83.
    View in: PubMed
    Score: 0.021
  79. Misconceptions with staging of soft tissue sarcoma. J Clin Oncol. 2000 Apr; 18(8):1800-1.
    View in: PubMed
    Score: 0.020
  80. Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas. J Clin Oncol. 1999 Sep; 17(9):2772-80.
    View in: PubMed
    Score: 0.020
  81. Preoperative chemotherapy for stage IIIB extremity soft tissue sarcoma: long-term results from a single institution. J Clin Oncol. 1997 Dec; 15(12):3481-7.
    View in: PubMed
    Score: 0.017
  82. Progressive and Reversible Conduction Disease With Checkpoint Inhibitors. Can J Cardiol. 2017 10; 33(10):1335.e13-1335.e15.
    View in: PubMed
    Score: 0.017
  83. Treatment of the patient with lung metastases. Curr Probl Surg. 1996 Nov; 33(11):881-952.
    View in: PubMed
    Score: 0.016
  84. In vivo biologic effects of PIXY321, a synthetic hybrid protein of recombinant human granulocyte-macrophage colony-stimulating factor and interleukin-3 in cancer patients with normal hematopoiesis: a phase I study. Blood. 1995 Sep 15; 86(6):2098-105.
    View in: PubMed
    Score: 0.015
  85. Effects of PIXY321, a granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein, on chemotherapy-induced multilineage myelosuppression in patients with sarcoma. J Clin Oncol. 1994 Apr; 12(4):715-24.
    View in: PubMed
    Score: 0.013
  86. Single-agent ifosfamide studies in sarcomas of soft tissue and bone: the M.D. Anderson experience. Cancer Chemother Pharmacol. 1993; 31 Suppl 2:S174-9.
    View in: PubMed
    Score: 0.012
  87. Metastatic cancer to the testes: a report of 20 cases and review of the literature. J Urol. 1989 Oct; 142(4):1003-5.
    View in: PubMed
    Score: 0.010
  88. Importance of predosing of recombinant human thrombopoietin to reduce chemotherapy-induced early thrombocytopenia. J Clin Oncol. 2003 Aug 15; 21(16):3158-67.
    View in: PubMed
    Score: 0.006
  89. Kinetic response of human marrow myeloid progenitor cells to in vivo treatment of patients with granulocyte colony-stimulating factor is different from the response to treatment with granulocyte-macrophage colony-stimulating factor. Exp Hematol. 1994 Jan; 22(1):100-2.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.